World vaccine development in the global pandemic era has made significant progress in a short time. The COVID-19 pandemic, which began in late 2019, pushed scientists and pharmaceutical companies to innovate quickly and efficiently to produce safe and effective vaccines. Several new and traditional methods have been used, including mRNA, viral vectors, and recombinant proteins. mRNA vaccines, such as BNT162b2 from Pfizer-BioNTech and mRNA-1273 from Moderna, represent major breakthroughs in vaccine technology. Different from conventional vaccines, mRNA vaccines instruct the body’s cells to produce viral proteins, which then stimulate an immune response. This method allows vaccine development in a shorter time and increases responsiveness to virus variants. Meanwhile, viral vector vaccines, such as ChAdOx1-S from AstraZeneca and Sputnik V, use a harmless virus to carry the SARS-CoV-2 virus protein gene into the body. This triggers a strong immune response without causing disease. This type of vaccine has been proven effective in reducing severe COVID-19 symptoms and death. Apart from new methods, traditional approaches are still used, such as vaccines based on inactivated or attenuated viruses. China’s Sinovac and Sinopharm vaccines use this technique, providing an option for countries that need quick access to vaccines. This suggests that variations in vaccine technology are key to fighting the pandemic globally. The importance of vaccine distribution cannot be ignored either. Programs like COVAX play a role in ensuring equitable access to vaccines for developing countries. Distribution of vaccine doses also faces logistical challenges, especially in maintaining the required storage temperatures. Innovations in storage and transportation, such as the use of temperature preservation boxes, play an important role in ensuring vaccines get into the arms of people who need them. The social and economic impact of mass vaccination is very significant. Countries that successfully carry out high levels of vaccination show a decrease in cases of infection and hospitalization. This allows the reopening of the economy, slowly returning people to normal life. Vaccination not only protects individuals, but also creates herd immunity which is essential in controlling the spread of the virus. With the emergence of new variants of COVID-19, such as Delta and Omicron, adjustments in vaccination strategies continue to be made. Booster shots are being introduced to increase immunity after the initial dose, and research is ongoing to create vaccines that can protect against various variants. International collaboration in vaccine research and development is becoming increasingly important to overcome this challenge. In closing, the development of vaccines in the global pandemic era shows the success of collaboration between scientists, government and the pharmaceutical industry. The speed and success of vaccine development provides new hope in the fight against the pandemic, while paving the way for future vaccine research. With continuous innovation, the world can be better prepared to face global health threats in the future.
